Notice of Change to PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"

Notice Number: NOT-DA-20-027

Key Dates
Release Date: December 13, 2019

Related Announcements
PAR-19-064

Issued by
National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform interested applicants that the application due dates for the Funding Opportunity Announcement (FOA)PAR-19-064 "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)" have changed.

The FOA has been modified as follows:

Key Dates:

Currently reads:

Application Due Date(s): February 8, 2019; June 7, 2019; November 8, 2019; February 7, 2020; June 8, 2020; November 6, 2020; February 8, 2021; June 8, 2021; November 8, 2021

Modified to read:

Application Due Date(s): February 8, 2019; June 7, 2019; November 8, 2019; February 7, 2020; June 8, 2020; October 6, 2020; February 8, 2021; June 8, 2021; October 8, 2021

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Marsha F. Lopez, PhD, MHS
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: [email protected])